Matches 1 - 24 out of 24


Match Document Document Title Score
US20170218089 COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES  
Described herein are peptides from secretory phospholipase A2-IB and antibodies that can be used to reduce the contribution of the gastrointestinal tract to inflammatory processes including...
1000
US20140193395 SECRETORY IGA COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF  
Described herein is secretory IgA isolated from the intestinal luminal fluid and intestinal mucosal of animals such as pigs and cows. Also included are methods of isolating secretory IgA. The...
984
US20160362477 SECRETORY IGA COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF  
Described herein is secretory IgA isolated from the intestinal luminal fluid and intestinal mucosal of animals such as pigs and cows. Also included are methods of isolating secretory IgA. The...
984
US20190045830 COATED EGG YOLK CORES, METHODS OF MAKING AND METHODS OF USE THEREOF  
A method of making coated avian egg yolk cores includes providing dried avian egg yolk cores having a diameter of 100 to 1500 micrometers, applying avian egg albumen to the dried avian egg yolk...
967
US20190062406 METHODS OF USE OF SECRETORY IgA  
Described herein dog and cat food additives and compositions comprising secretory IgA.
956
US20170044251 INTERLEUKIN-10 PEPTIDES AND ANTIBODIES THEREOF FOR INHIBITING ADVERSE EFFECTS OF PROTOZOAN INFECTION  
The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be...
940
US20160318994 METHODS OF USE OF SECRETORY IgA  
Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an...
896
US20140127190 COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES  
Described herein are peptides from secretory phospholipase A2-IB and antibodies that can be used to reduce the contribution of the gastrointestinal tract to inflammatory processes including...
841
8652457 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection  
The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be...
813
US20140017248 INTERLEUKIN-10 PEPTIDES AND ANTIBODIES THEREOF FOR INHIBITING ADVERSE EFFECTS OF PROTOZOAN INFECTION  
The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be...
813
US20140127220 INTERLEUKIN-10 PEPTIDES AND ANTIBODIES THEREOF FOR INHIBITING ADVERSE EFFECTS OF PROTOZOAN INFECTION  
The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be...
766
9657109 Compositions and methods for the treatment of systemic inflammatory response syndromes  
Described herein are peptides from secretory phospholipase A2-IB and antibodies that can be used to reduce the contribution of the gastrointestinal tract to inflammatory processes including...
728
US20150086534 METHODS OF USE OF SECRETORY IgA  
Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an...
720
US20160008436 METHODS OF CONTROLLING PARASITIC WORMS IN ANIMALS  
Disclosed herein are methods of controlling parasitic worms in herbivorous mammals and other species by orally administering an isolated antibody that specifically binds the interleukin-10 peptide...
694
US20160280778 COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 PEPTIDES AND ANTI-INTERLEUKIN-10 ANTIBODIES  
Disclosed herein are methods of reducing a symptom of respiratory disease in a pre-weaned milk-fed mammal by orally administering an isolated antibody that specifically binds the interleukin-10...
623
US20150037277 METHODS OF REDUCING SALMONELLA IN POULTRY  
Described herein are methods of reducing Salmonella in the intestines of poultry in need thereof by administering to a poultry bird an effective amount of an interleukin-10 peptide or an isolated...
616
9505836 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection  
The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be...
611
9458230 Secretory IGA compositions, methods of making and methods of use thereof  
Described herein is secretory IgA isolated from the intestinal luminal fluid and intestinal mucosal of animals such as pigs and cows. Also included are methods of isolating secretory IgA. The...
601
US20150313964 METHODS OF REDUCING SALMONELLA IN POULTRY  
Described herein are methods of reducing Salmonella in the intestines of poultry in need thereof by administering to a poultry bird an effective amount of an interleukin-10 peptide or an isolated...
563
9468674 Methods of use of secretory IgA  
Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an...
561
10017569 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection  
The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be...
510
9821028 Methods of controlling parasitic worms in animals  
Disclosed herein are methods of controlling parasitic worms in herbivorous mammals and other species by orally administering an isolated antibody that specifically binds the interleukin-10 peptide...
471
10144773 Methods of use of secretory IgA  
Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an...
464
9821029 Methods of reducing salmonella in poultry  
Described herein are methods of reducing Salmonella in the intestines of poultry in need thereof by administering to a poultry bird an effective amount of an interleukin-10 peptide or an isolated...
392


Search
Matches 1 - 24 out of 24
« search again